Second, given the known regional/ethnic variability in ARVD/C-associated pathogenic mutations leading to unbalanced predominance of PKP2-positive patients in our North-American cohort, we are limited in our ability to draw statistically significant conclusions with regards to any genetic association in terms of LV involvement. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.